SAROJA
Start SIP
Invest Now
Start SIP in SAROJA
Performance
- Low
- ₹34
- High
- ₹36
- 52 Week Low
- ₹34
- 52 Week High
- ₹60
- Open Price₹34
- Previous Close₹36
- Volume4,800
- 50 DMA₹42.37
- 100 DMA₹43.79
- 200 DMA₹46.04
Investment Returns
- Over 1 Month -16.28%
- Over 3 Month -23.57%
- Over 6 Month 0%
- Over 1 Year -32.96%
Smart Investing Starts Here Start SIP with Saroja Pharma Industries India for Steady Growth!
Saroja Pharma Industries India Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.
- P/E Ratio
- 14
- PEG Ratio
- -
- Market Cap Cr
- 15
- P/B Ratio
- 0.9
- Average True Range
- 1.53
- EPS
- 2.57
- Dividend Yield
- 0
- MACD Signal
- -1.41
- RSI
- 34.44
- MFI
- 39.73
Saroja Pharma Industries India Financials
Saroja Pharma Industries India Technicals
EMA & SMA
Current Price
₹36.00
+
0.3
(0.84%)
- Bearish Moving Average 16
- Bullish Moving Average 0
- 20 Day
- ₹40.42
- 50 Day
- ₹42.37
- 100 Day
- ₹43.79
- 200 Day
- ₹46.04
Resistance and Support
35.47
- R3 38.13
- R2 37.07
- R1 36.53
- S1 34.93
- S2 33.87
- S3 33.33
Saroja Pharma Industries India Corporate Actions - Bonus, Splits, Dividends
| Date | Purpose | Remarks |
|---|---|---|
| 2025-11-13 | Quarterly Results | |
| 2024-11-13 | Quarterly Results | |
| 2024-05-29 | Audited Results |
Saroja Pharma Industries India F&O
About Saroja Pharma Industries India
- NSE Symbol
- SAROJA
- BSE Symbol
- Chairman & Managing Director
- Mr. Biju Gopinathan Nair
- ISIN
- INE0PCL01011
Similar Stocks to Saroja Pharma Industries India
Saroja Pharma Industries India FAQs
Saroja Pharma Industries India share price is ₹36 As on 15 January, 2026 | 01:33
The Market Cap of Saroja Pharma Industries India is ₹14.5 Cr As on 15 January, 2026 | 01:33
The P/E ratio of Saroja Pharma Industries India is 14 As on 15 January, 2026 | 01:33
The PB ratio of Saroja Pharma Industries India is 0.9 As on 15 January, 2026 | 01:33
Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.